← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

OSUR logoOraSure Technologies, Inc.(OSUR)Earnings, Financials & Key Ratios

OSUR•NASDAQ
$3.00
$217M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDiagnostics and life science tools
AboutOraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.Show more
  • Revenue$115K-99.9%
  • EBITDA-$68K+99.6%
  • Net Income-$69K+99.6%
  • EPS (Diluted)-0.94-261.5%
  • Gross Margin41.9%-1.9%
  • EBITDA Margin-59.23%-513.4%
  • Operating Margin-59.23%-289.6%
  • Net Margin-59.76%-469.4%
Technical→

OSUR Key Insights

OraSure Technologies, Inc. (OSUR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Weak 3Y average ROE of 4.4%
  • ✗Negative free cash flow
  • ✗Sales declining 76.8% over 5 years
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

OSUR Price & Volume

OraSure Technologies, Inc. (OSUR) stock price & volume — 10-year historical chart

Loading chart...

OSUR Growth Metrics

OraSure Technologies, Inc. (OSUR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-50.08%
5 Years-76.82%
3 Years-93.33%
TTM-99.94%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-153.66%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-261.59%

Return on Capital

10 Years3.75%
5 Years-1.34%
3 Years0.53%
Last Year-0.03%

OSUR Recent Earnings

OraSure Technologies, Inc. (OSUR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 9/12 qtrs (75%)
Q1 2026Latest
Feb 25, 2026
EPS
$0.19
Est $0.17
-11.8%
Revenue
$27M
Est $26M
+1.0%
Q4 2025
Nov 5, 2025
EPS
$0.13
Est $0.16
+18.8%
Revenue
$27M
Est $26M
+2.4%
Q3 2025
Aug 5, 2025
EPS
$0.19
Est $0.15
-26.7%
Revenue
$31,242
Est $33,969
-8.0%
Q2 2025
May 7, 2025
EPS
$0.18
Est $0.15
-20.0%
Revenue
$934,000
Est $30M
-96.8%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 25, 2026
$0.19vs $0.17-11.8%
$27Mvs $26M+1.0%
Q4 2025Nov 5, 2025
$0.13vs $0.16+18.8%
$27Mvs $26M+2.4%
Q3 2025Aug 5, 2025
$0.19vs $0.15-26.7%
$31,242vs $33,969-8.0%
Q2 2025May 7, 2025
$0.18vs $0.15-20.0%
$934,000vs $30M-96.8%
Based on last 12 quarters of dataView full earnings history →

OSUR Peer Comparison

OraSure Technologies, Inc. (OSUR) competitors in Diagnostics and life science tools — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
QDEL logoQDELQuidelOrtho CorporationDirect Competitor793.83M11.66-0.70-1.89%-45.57%-56.31%1.46
IDXX logoIDXXIDEXX Laboratories, Inc.Direct Competitor44.83B562.9743.0410.42%24.63%70.87%2.35%0.67
ABT logoABTAbbott LaboratoriesProduct Competitor151.59B87.1811.414.59%31.88%27.26%4.19%0.32
BDX logoBDXBecton, Dickinson and CompanyProduct Competitor52.23B144.1724.738.23%8.01%6.93%5.11%0.76
HOLX logoHOLXHologic, Inc.Product Competitor16.97B76.0130.531.74%13.18%10.37%5.42%0.52
NEOG logoNEOGNeogen CorporationProduct Competitor2.02B9.27-1.84-3.2%-68.47%-28.64%0.44
CLOV logoCLOVClover Health Investments, Corp.Product Competitor1.35B2.61-15.3540.34%-4.45%-27.71%
TMO logoTMOThermo Fisher Scientific Inc.Supply Chain173.46B466.7626.313.91%15.18%13.23%3.63%0.76

Compare OSUR vs Peers

OraSure Technologies, Inc. (OSUR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs QDEL

Most directly comparable listed peer for OSUR.

Scale Benchmark

vs TMO

Larger-name benchmark to compare OSUR against a more recognizable public peer.

Peer Set

Compare Top 5

vs QDEL, IDXX, ABT, BDX

OSUR Income Statement

OraSure Technologies, Inc. (OSUR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue167.06M181.74M154.6M171.72M233.67M387.48M405.47M185.83M115.02K
Revenue Growth %30.32%8.79%-14.93%11.07%36.08%65.82%4.64%-54.17%-99.94%
Cost of Goods Sold68.11M68.13M60.02M69.85M116.07M239.04M226.05M106.44M66.82K
COGS % of Revenue40.77%37.49%38.82%40.68%49.67%61.69%55.75%57.28%58.1%
Gross Profit
98.96M▲ 0%
113.61M▲ 14.8%
94.58M▼ 16.7%
101.87M▲ 7.7%
117.6M▲ 15.4%
148.44M▲ 26.2%
179.42M▲ 20.9%
79.39M▼ 55.8%
48.2K▼ 99.9%
Gross Margin %59.23%62.51%61.18%59.32%50.33%38.31%44.25%42.72%41.9%
Gross Profit Growth %12.42%14.81%-16.75%7.7%15.44%26.22%20.87%-55.75%-99.94%
Operating Expenses71.22M85.18M75.97M107.05M127.76M170.59M146.74M107.64M116.32K
OpEx % of Revenue42.63%46.87%49.14%62.34%54.68%44.03%36.19%57.92%101.13%
Selling, General & Admin57.85M68.93M67.16M77.11M95.08M117.44M92.18M77.2M73.79K
SG&A % of Revenue34.63%37.93%43.44%44.91%40.69%30.31%22.73%41.54%64.16%
Research & Development13.37M16.25M19.63M31.03M34.17M36.24M33.73M26.05M42.53K
R&D % of Revenue8%8.94%12.7%18.07%14.62%9.35%8.32%14.02%36.97%
Other Operating Expenses00-10.81M-1.1M-1.49M16.91M20.83M4.39M0
Operating Income
40.24M▲ 0%
28.43M▼ 29.3%
18.61M▼ 34.5%
-5.18M▼ 127.8%
-10.16M▼ 96.3%
-22.16M▼ 118.0%
32.68M▲ 247.5%
-28.25M▼ 186.4%
-68.12K▲ 99.8%
Operating Margin %24.09%15.64%12.04%-3.01%-4.35%-5.72%8.06%-15.2%-59.23%
Operating Income Growth %98.56%-29.35%-34.54%-127.82%-96.33%-117.99%247.52%-186.43%99.76%
EBITDA46.64M34.88M26.34M4.54M2.33M-6.62M53.62M-17.94M-68.12K
EBITDA Margin %27.92%19.19%17.04%2.64%1%-1.71%13.22%-9.66%-59.23%
EBITDA Growth %79.72%-25.21%-24.48%-82.78%-48.62%-384%910.02%-133.46%99.62%
D&A (Non-Cash Add-back)6.4M6.45M7.73M9.71M12.49M15.54M20.94M10.31M0
EBIT27.74M28.43M7.8M-6.28M-11.65M-5.24M43.41M-23.86M0
Net Interest Income000000000
Interest Income000000000
Interest Expense000000000
Other Income/Expense794K3.29M2.72M1.65M872K6.48M23.57M10.55M3.54K
Pretax Income
41.03M▲ 0%
31.72M▼ 22.7%
21.33M▼ 32.7%
-3.52M▼ 116.5%
-9.29M▼ 163.7%
-15.68M▼ 68.7%
56.26M▲ 458.9%
-17.7M▼ 131.5%
-64.59K▲ 99.6%
Pretax Margin %24.56%17.45%13.8%-2.05%-3.98%-4.05%13.87%-9.53%-56.15%
Income Tax10.08M11.32M4.67M11.4M13.71M1.46M2.6M1.8M1.8K
Effective Tax Rate %24.58%35.69%21.92%-323.44%-147.5%-9.3%4.63%-10.16%-2.79%
Net Income
30.95M▲ 0%
20.4M▼ 34.1%
16.66M▼ 18.3%
-14.92M▼ 189.6%
-23M▼ 54.1%
-17.13M▲ 25.5%
53.66M▲ 413.2%
-19.5M▼ 136.3%
-68.73K▲ 99.6%
Net Margin %18.52%11.22%10.77%-8.69%-9.84%-4.42%13.23%-10.49%-59.76%
Net Income Growth %56.94%-34.1%-18.34%-189.59%-54.12%25.5%413.17%-136.34%99.65%
Net Income (Continuing)30.95M20.4M16.66M-14.92M-23M-17.13M53.66M-19.5M-68.73K
Discontinued Operations000000000
Minority Interest000000000
EPS (Diluted)
0.51▲ 0%
0.33▼ 35.3%
0.27▼ 18.2%
-0.22▼ 181.5%
-0.32▼ 45.5%
-0.25▲ 21.9%
0.72▲ 388.0%
-0.26▼ 136.1%
-0.94▼ 261.5%
EPS Growth %45.71%-35.29%-18.18%-181.48%-45.45%21.88%388%-136.11%-261.54%
EPS (Basic)0.520.330.27-0.22-0.32-0.250.73-0.26-0.94
Diluted Shares Outstanding61.02M62.53M62.17M67.5M71.98M72.5M74.39M74.43M73.48M
Basic Shares Outstanding59.05M61.11M61.67M67.5M71.98M72.5M73.35M74.43M73.48M
Dividend Payout Ratio---------

OSUR Balance Sheet

OraSure Technologies, Inc. (OSUR) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets221.91M219.31M224.55M288.89M299.31M325.19M386.46M333.22M252.54K
Cash & Short-Term Investments155.9M156.57M156.34M209.4M153.04M110.85M290.41M267.76M199.28K
Cash Only72.87M88.44M75.72M160.8M116.76M83.98M290.41M267.76M199.28K
Short-Term Investments83.03M68.13M80.62M48.6M36.28M26.87M000
Accounts Receivable42.52M34.84M36.95M38.84M45.32M70.8M40.17M23.82M22.2K
Days Sales Outstanding92.969.9787.2382.5570.7966.6936.1646.7870.46
Inventory19.34M22.89M23.16M31.86M53.14M95.7M47.61M34.2M31.06K
Days Inventory Outstanding103.66122.62140.81166.49167.09146.1376.88117.27169.66
Other Current Assets4.33M3.08M5.68M4.93M39.87M41.57M2.23M3.49M0
Total Non-Current Assets74.3M96.26M124.75M165.58M161.68M118.99M96.39M146.44M101.59K
Property, Plant & Equipment21.37M24.3M37.29M57.63M84.98M71.11M58.27M58.69M39.18K
Fixed Asset Turnover7.82x7.48x4.15x2.98x2.75x5.45x6.96x3.17x2.94x
Goodwill20.08M18.52M36.2M40.35M40.28M35.1M35.7M40.33M43.36K
Intangible Assets8.22M5.14M14.67M17.9M14.34M11.69M1.21M17.43M19.05K
Long-Term Investments20.69M44.75M33.42M47.72M17.01M0028.3M0
Other Non-Current Assets1.98M3.55M3.16M1.97M5.07M1.09M1.22M1.53M0
Total Assets
296.2M▲ 0%
315.57M▲ 6.5%
349.3M▲ 10.7%
454.47M▲ 30.1%
460.99M▲ 1.4%
444.18M▼ 3.6%
482.85M▲ 8.7%
479.66M▼ 0.7%
403.17K▼ 99.9%
Asset Turnover0.56x0.58x0.44x0.38x0.51x0.87x0.84x0.39x0.29x
Asset Growth %42.45%6.54%10.69%30.11%1.43%-3.65%8.7%-0.66%-99.92%
Total Current Liabilities32.24M27.98M32.71M46.49M68.06M69.06M39.54M33.48M8.04K
Accounts Payable10.23M10.6M9.57M17.41M28.02M38.02M13.15M8.17M6.52K
Days Payables Outstanding54.8156.7858.1890.9688.1258.0521.2328.0335.62
Short-Term Debt000000000
Deferred Revenue (Current)1.31M3.52M3.71M4.81M2.94M2.27M1.56M2.96M1.52K
Other Current Liabilities4.96M3.49M8.93M4.48M4.75M5.52M3.98M5.22M0
Current Ratio6.88x7.84x6.86x6.21x4.40x4.71x9.77x9.95x31.41x
Quick Ratio6.28x7.02x6.16x5.53x3.62x3.32x8.57x8.93x27.55x
Cash Conversion Cycle141.75135.82169.86158.08149.77154.7791.81136.02204.49
Total Non-Current Liabilities5.88M4.21M9.44M9.41M12.39M10.69M12.64M35.84M0
Long-Term Debt000000000
Capital Lease Obligations005.58M4.49M9.15M9.6M11.39M12.43M0
Deferred Tax Liabilities1.95M3.31M899K1.2M2.23M408K554K00
Other Non-Current Liabilities3.93M02.96M3.73M1M680K696K23.4M0
Total Liabilities38.12M32.19M42.15M55.9M80.46M79.75M52.17M69.32M0
Total Debt007.22M6.13M12.27M12.55M13.5M14.6M0
Net Debt-72.87M-88.44M-68.49M-154.67M-104.49M-71.43M-276.9M-253.16M-199.28K
Debt / Equity--0.02x0.02x0.03x0.03x0.03x0.04x-
Debt / EBITDA--0.27x1.35x5.27x-0.25x--
Net Debt / EBITDA-1.56x-2.54x-2.60x-34.09x-44.83x--5.16x--
Interest Coverage---------
Total Equity
258.08M▲ 0%
283.38M▲ 9.8%
307.14M▲ 8.4%
398.57M▲ 29.8%
380.53M▼ 4.5%
364.43M▼ 4.2%
430.67M▲ 18.2%
410.34M▼ 4.7%
0▼ 100.0%
Equity Growth %38.87%9.8%8.39%29.77%-4.53%-4.23%18.18%-4.72%-100%
Book Value per Share4.234.534.945.905.295.035.795.51-
Total Shareholders' Equity258.08M283.38M307.14M398.57M380.53M364.43M430.67M410.34M0
Common Stock000000000
Retained Earnings-119.51M-99.19M-82.53M-97.45M-120.45M-137.59M-83.93M-103.43M0
Treasury Stock000000000
Accumulated OCI-10.34M-18.71M-12.14M-9.1M-10.08M-18.43M-14.94M-24.36M0
Minority Interest000000000

OSUR Cash Flow Statement

OraSure Technologies, Inc. (OSUR) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations28.16M39.09M9.8M5.81M-35.38M-47.2M141.58M27.37M-49.02K
Operating CF Margin %16.85%21.51%6.34%3.38%-15.14%-12.18%34.92%14.73%-42.62%
Operating CF Growth %23.67%38.83%-74.92%-40.77%-709.3%-33.41%399.95%-80.67%-100.18%
Net Income30.95M20.4M16.66M-14.92M-23M-17.93M53.66M-19.5M-68.73K
Depreciation & Amortization6.4M7.22M7.73M9.71M12.49M15.54M20.94M10.87M10.19K
Stock-Based Compensation6.97M15.24M4.06M7.14M7.81M11.62M10.73M11.92M10.15K
Deferred Taxes-649K-919K-1.46M-392K1.03M-1.65M102K-657K-103
Other Non-Cash Items131K-400K-8.28M-424K4.72M15.79M10.4M5.92M-528
Working Capital Changes-15.65M-2.45M-8.9M4.69M-38.44M-70.56M45.76M18.82M0
Change in Receivables-22.12M6.63M-2.21M-2.32M-6.45M-25.16M31.12M15.87M1.95K
Change in Inventory-7.39M-3.86M-1.04M-8.61M-27.94M-43.05M48.23M13.1M3.56K
Change in Payables5.16M208K-1.54M7.38M3.23M3.96M-26.98M-7.58M-1.72K
Cash from Investing-96.35M-17.43M-19.8M-14.03M-5.5M21.09M66.15M-39.03M-6.81K
Capital Expenditures-4.34M-6.34M-9.31M-28.92M-48.12M-63.91M-10.3M-3.8M-4.2K
CapEx % of Revenue2.6%3.49%6.02%16.84%20.59%16.49%2.54%2.04%3.65%
Acquisitions00-11.8M-3.04M0121K0-5.04M-3.61K
Investments---------
Other Investing-92.02M-11.08M0351K513K60.33M48.67M-30M1K
Cash from Financing30.43M-1.89M-4.68M92.48M-2.82M-3.83M-3.02M-4.18M-16.94K
Debt Issued (Net)00-1.17M-687K-686K-1.38M-1.34M-842K0
Equity Issued (Net)-1000K-1000K-1000K1000K-1000K-1000K-1000K-1000K0
Dividends Paid000000000
Share Repurchases-1.24M-3.59M-3.71M-2.09M-2.11M-2.25M-1.9M-3.55M-15.04K
Other Financing31.68M1.7M196K218K-18K-193K223K214K-16.94K
Net Change in Cash
-36.92M▲ 0%
15.57M▲ 142.2%
-12.72M▼ 181.7%
85.09M▲ 768.8%
-44.04M▼ 151.8%
-32.78M▲ 25.6%
206.43M▲ 729.7%
-22.64M▼ 111.0%
-68.48K▲ 99.7%
Free Cash Flow
23.82M▲ 0%
32.75M▲ 37.5%
490K▼ 98.5%
-23.12M▼ 4817.8%
-83.5M▼ 261.2%
-111.11M▼ 33.1%
131.28M▲ 218.2%
23.58M▼ 82.0%
-53.22K▼ 100.2%
FCF Margin %14.26%18.02%0.32%-13.46%-35.73%-28.68%32.38%12.69%-46.27%
FCF Growth %29.35%37.48%-98.5%-4817.76%-261.2%-33.07%218.15%-82.04%-100.23%
FCF per Share0.390.520.01-0.34-1.16-1.531.760.32-0.00
FCF Conversion (FCF/Net Income)0.91x1.92x0.59x-0.39x1.54x2.76x2.64x-1.40x0.71x
Interest Paid000000000
Taxes Paid000000000

OSUR Key Ratios

OraSure Technologies, Inc. (OSUR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)11.42%13.94%7.53%5.64%-4.23%-5.9%-4.6%13.5%-4.64%-
Return on Invested Capital (ROIC)21.5%23.1%11.22%6.44%-1.61%-2.93%-5.84%10.97%-13.63%-
Gross Margin68.66%59.23%62.51%61.18%59.32%50.33%38.31%44.25%42.72%41.9%
Net Margin15.38%18.52%11.22%10.77%-8.69%-9.84%-4.42%13.23%-10.49%-59.76%
Debt / Equity---0.02x0.02x0.03x0.03x0.03x0.04x-
FCF Conversion1.15x0.91x1.92x0.59x-0.39x1.54x2.76x2.64x-1.40x0.71x
Revenue Growth7.08%30.32%8.79%-14.93%11.07%36.08%65.82%4.64%-54.17%-99.94%

OSUR SEC Filings & Documents

OraSure Technologies, Inc. (OSUR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 30, 2026·SEC

Material company update

Mar 5, 2026·SEC

Material company update

Feb 25, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 9, 2026·SEC

FY 2025

Mar 7, 2025·SEC

FY 2024

Mar 11, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 7, 2025·SEC

OSUR Frequently Asked Questions

OraSure Technologies, Inc. (OSUR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

OraSure Technologies, Inc. (OSUR) reported $0.1M in revenue for fiscal year 2025. This represents a 100% decrease from $68.7M in 1996.

OraSure Technologies, Inc. (OSUR) saw revenue decline by 99.9% over the past year.

OraSure Technologies, Inc. (OSUR) reported a net loss of $49.5M for fiscal year 2025.

Dividend & Returns

OraSure Technologies, Inc. (OSUR) had negative free cash flow of $93.4M in fiscal year 2025, likely due to heavy capital investments.

Explore More OSUR

OraSure Technologies, Inc. (OSUR) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.